The 2026 National Health Care Fraud Takedown: False Orders, Invented Care

Whistleblower Justice Network

The 2026 national Medicare fraud takedown was a coordinated health care enforcement action that the Justice Department announced on June 23, covering Medicare, Medicaid and other insurers. The national announcement reported charges involving more than $6.5 billion in alleged false claims. Behind that headline were forged orders, claims for care never delivered and payments allegedly concealed behind ordinary business records. If you know who ordered the test, whether the patient received care or where the money went, you may recognize what the headline cannot show.

455 Defendants in One National Healthcare Fraud Action

The national healthcare fraud action included 90 doctors and other licensed medical professionals, across 56 federal districts and 45 states and territories, with 50 state Medicaid Fraud Control Units taking part. The Health Care Fraud Unit coordinated the action with U.S. Attorneys’ Offices, the Department of Health and Human Services Office of Inspector General, the Federal Bureau of Investigation, the Drug Enforcement Administration and the state units.

The Justice Department had announced the creation of its National Fraud Enforcement Division on April 7. The division’s Health Care Strike Force program comprised nine strike forces operating across federal districts.

The 2026 Healthcare Fraud Takedown Payer Breakdown

The 2026 healthcare fraud takedown payer breakdown includes a separately reported Medicaid group of 295 defendants and more than $518 million in alleged false claims. Individual cases also involved several programs.

The allegations against Alpha Care Medical show why the Medicare and Medicaid distinction matters inside a single case. According to the department’s case summaries, a civil complaint accused the practice, its principal and its laboratory director of submitting claims for unnecessary urine drug tests and tests never performed. The named payers were Medicare, the Delaware Medical Assistance Program, TRICARE and the Federal Employee Health Benefits Program.

One practice. Several public programs. For an insider, the useful connection runs from the test and the order to the particular program billed and the payment received.

The 2026 Takedown Civil and Criminal Outcomes

The 2026 takedown civil and criminal outcomes included new charges, civil settlements and administrative actions stopping payments or removing billing privileges. On the civil side, the department reported charges against 13 defendants involving $14.8 million in alleged schemes. Separately, it announced civil settlements with 31 defendants totaling $23 million.

The Health and Human Services Office of Inspector General reported 48 civil monetary penalty settlements amounting to more than $73 million. It also brought 25 actions seeking more than $10 billion from money the Centers for Medicare and Medicaid Services had suspended before providers received it.

The Centers for Medicare and Medicaid Services suspended 1,079 providers and revoked billing privileges for 1,403. A payment suspension holds money while an investigation proceeds. Revocation removes billing privileges. The Drug Enforcement Administration reported 928 administrative cases seeking to revoke authority to handle or prescribe controlled substances since October 1, 2025.

What the Cases Show Inside the Business

The cases connect claims to records that employees, clinicians, billing staff and business partners may know firsthand. A requisition, a lease or an invoice can look routine until someone explains how it was created and what it concealed.

Forged Orders From Clinicians Who Never Ordered the Tests

A June 16, 2026 criminal indictment in Los Angeles charged a medical office manager with using a physician’s and nurse practitioners’ names and forged signatures on laboratory requisitions. The physician was living in Hungary when the manager allegedly used his identity to order tests. The nurse practitioners allegedly had no knowledge of companies that the forms identified as their employers.

The indictment alleged that the manager supplied beneficiary information even when patients had provided no specimens, including patients who were already dead on the supposed collection date. She allegedly sent the requisitions to a laboratory intending that it bill Medicare and make payments to her and others.

The same indictment describes a false commercial lease and an altered business-address filing. The alleged fabrication extended beyond the doctor’s signature to the paperwork making the practice appear to operate at that address.

That is why stolen Medicare numbers and forged orders involve more than an identifier on a claim. The clinician’s actual work, the specimen record and the laboratory’s billing each supply a different part of the story. An employee who knows where the order came from may explain a discrepancy that the claim alone conceals.

Hospice Records Created to Improve the Numbers

The Justice Department’s account of criminal charges in Los Angeles described a hospice owner who allegedly bought recently deceased beneficiaries’ information from a funeral home employee. The owner allegedly billed for hospice services those people had never received and created backdated medical records saying a physician had seen them.

The alleged purpose was particularly revealing. The owner believed investigators watched the percentage of hospice patients discharged alive, so adding deceased beneficiaries would reduce that figure and make the business look less suspicious.

We see a particularly cynical allegation here: the supposed patient care was invented to make the fraud indicator look better. The phantom billing and the fabricated medical record served the same business objective. Someone who handled admissions or knew how the records were made could explain what the billing statistics obscured.

Wound-Product Invoices That Concealed the Actual Cost

The Arizona criminal indictment, as described in the department’s case summaries, charged a wound-product sales executive with concealing kickbacks and rebates behind inflated invoices. Providers allegedly received invoices showing more than their actual allograft cost and were directed to use those amounts for Medicare reimbursement.

The national announcement put Medicare billings for the company’s allografts at over $4 billion, with over $2 billion paid. The allegations described tissue bought from tissue banks and relabeled at a 2,000% markup, charging up to $1,450 per square centimeter. The Centers for Medicare and Medicaid Services separately reduced Medicare’s payment to $127 per square centimeter starting January 1, 2026.

The government also alleged that pass-through accounts at a shell company concealed payments to providers for buying the products. The financial incentives allegedly drove unnecessary treatment, including treatment of elderly patients receiving hospice care.

The national announcement described allegations that grafts covered areas larger than the wounds and were applied without proper treatment for infection. The wound assessment, product quantity, sales invoice and rebate payment tell different parts of that alleged scheme. A person in purchasing or accounts payable may know the real acquisition cost even without participating in the treatment decision.

In a separate Texas criminal case, the announcement described a nurse practitioner charged with a $906 million scheme involving unnecessary allografts and Medicare billings averaging more than $1 million per patient. The wound assessment, product quantity and invoice help connect the treatment to the bill.

An Enrollment Application That Hid Another Laboratory

Coastal Diagnostics and its owner agreed to pay more than $145,000 in a civil settlement over alleged Medicaid enrollment fraud. The department’s Connecticut case summary alleged that their application concealed a relationship with another laboratory at the same address, where Coastal’s owner served as chief operating officer.

The government alleged that the other laboratory was under a payment suspension and fraud investigation, and that a truthful application would have prevented Coastal’s enrollment. This is a different route to the same underlying question: who was operating the business behind the billing authority?

The forged-order case concerned the alleged invention of ordering authority, while Coastal’s settlement concerned the alleged concealment of a business relationship. Both put ordinary administrative records beside the claims that followed.

Prescription Refills Without Speaking to the Patient

The announcement reported criminal charges against 36 defendants, including 28 licensed medical professionals, over alleged diversion of prescription opioids and other controlled substances. In Pennsylvania, the charges alleged that defendants operated a voicemail refill line that supplied controlled-substance prescriptions without interacting with patients, continuing even after patients using the line suffered fatal overdoses.

Operation Gold Rush: Billing for Equipment Never Delivered

The June announcement included a new criminal charge involving an additional $3.7 billion in allegedly false claims for urinary catheters and other durable medical equipment never provided, following the previous year’s Operation Gold Rush case. The June 18, 2025 Gold Rush indictment alleged approximately $10.6 billion in false Medicare claims, approximately $41 million paid by Medicare and an estimated approximately $900 million paid by supplemental insurers. The same indictment described the acquisition of enrolled equipment suppliers, nominee owners and transfers through shell companies and foreign accounts.

We see an enormous gap between what the suppliers allegedly billed Medicare and what Medicare paid, alongside substantial payments from supplemental insurers. The ownership filings and bank records explain who controlled the suppliers and where the proceeds went.

Is Stopped or Seized Money the Same as Money Returned to Medicare?

No. Stopped payments remain unpaid to the provider, seized assets are in government custody, and money returned to Medicare requires a transfer back to the program. The takedown announcement reported more than $182 million seized, including cash, vehicles, jewelry and other assets.

The distinction starts much earlier in how Medicare pays. A submitted charge records what the provider billed. The remittance records the payment decision and adjustments. The bank transfer shows money actually moved, with offsets potentially affecting the deposit.

For a billing insider, the evidence connecting orders, claims and payments gives these distinctions practical meaning. It connects the service described on paper to the service delivered and the money received. An invoice, a payment decision and a bank deposit answer different questions even when they concern the same patient.

Medicare Fraud Detection Needs More Than a Billing Spike

Medicare fraud detection in the takedown combined payment analysis with financial and patient records. In an Illinois Medicaid criminal case described in the announcement, the defendant allegedly billed for 500 or more hours of counseling and therapy per day, beyond what the staff could provide even working around the clock. Analysis also showed patients hospitalized elsewhere on days the business billed for their behavioral health care.

The department identified this as the first prosecution arising from its Data Fusion Center’s Financial Intelligence Review Team, which combined claims analytics with financial analysis. The center brought together the Health Care Fraud Unit’s analysts, the Health and Human Services Office of Inspector General, the Federal Bureau of Investigation and other agencies, and used analytics in many of the takedown cases. The alleged diversion of money to brokerage accounts and a luxury car dealership added a money trail to the impossible service hours.

The academic work helps explain why connecting these sources matters. Big Data fraud detection using multiple medicare data sources, published in the Journal of Big Data in 2018, tested combined physician, prescription and equipment data. Its combined dataset produced the highest individual model score, although performance across the models was not significantly different from using Part B data alone.

It also identifies a limitation in the list of excluded providers used to label the data:

The LEIE is aggregated at the provider-level and does not have specific information regarding procedures, drugs or equipment related to fraudulent activities.

Big Data fraud detection using multiple medicare data sources, Journal of Big Data, 2018

The missing detail is precisely what an insider can bring: which order, which drug or which shipment, and who made the decision behind it. The service described on paper can then be connected to the service delivered and the money received.

A later paper, Explainable machine learning models for Medicare fraud detection, Journal of Big Data, 2023, found that selecting fewer data features could preserve or improve classification performance while making models easier to explain. The June announcement included a further technology development: an agreement giving the Fraud Division cloud computing space inside the Centers for Medicare and Medicaid Services’ data environment. The agency also said it was developing Claims Core capabilities for electronic attestation, identity verification and login tracking. The concrete cases show the work that still matters around them: connecting a billing pattern to patients, records and money.

Do You Get a Reward for Reporting Fraud?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. The whistleblower reward follows that recovery. If the cases here resemble orders, invoices or ownership arrangements you know from work, we can assess how your knowledge connects the business conduct to the government’s payments.

You Know What Happened Before the Claim

If you know who supplied the false order, concealed the rebate or controlled the billing company, talk with our Medicare fraud whistleblower experts. We build a case strategy around that knowledge and bring in healthcare fraud whistleblower lawyers who understand the payment system and the business records. We stay beside you as we build your strongest Medicare fraud whistleblower case.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365